Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    24806159 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety and Efficacy Study of a New Antiviral Drug to Prevent Cytomegalovirus Reactivation in Bone Marrow Transplanted Patients
Condition: Cytomegalovirus
Interventions: Drug: AIC246;   Other: Placebo

Indicates status has not been verified in more than two years